Using trade names: A risk factor for accidental drug overdose

Archives of Internal Medicine

Volumn 162, Issue 9, 2002, Pages 1065-1066

  Schwab, Matthias ^a   Oetzel, Carsten ^b   Mörike, Klaus ^c   Jägle, Christine ^c   Gleiter, Christoph H ^c   Eichelbaum, Michel ^a,c  

^a DR MARGARETE FISCHER BOSCH INSTITUTE OF CLINICAL PHARMACOLOGY   (Germany)

^b ROBERT BOSCH HOSPITAL   (Germany)

^c Division of Clinical Pharmacology   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

NORVERAPAMIL; TRANDOLAPRIL PLUS VERAPAMIL; VERA; VERA LICH; VERAGAMMA; VERAHEXAL; VERANORM ISIS; VERAPAMIL; VERASAL; VEROPTINSTADA;

ADULT; ARTICLE; ATRIOVENTRICULAR BLOCK; CASE REPORT; DRUG OVERDOSE; FEMALE; HEART LEFT BUNDLE BRANCH BLOCK; HUMAN; KIDNEY DISEASE; PATIENT EDUCATION; PRESCRIPTION; PRIORITY JOURNAL;

EID: 0037071240     PISSN: 00039926     EISSN: None     Source Type: Journal    
DOI: 10.1001/archinte.162.9.1065     Document Type: Article

References (7)

1. Pharmacokinetic data for commonly used drugs
2. 7]verapamil and metabolites in biological fluids by liquid chromatography-mass spectrometry
3. Incidence of adverse drug reactions in hospitalized patients: A meta-analysis of prospective studies
4. Mechanisms of adverse drug reactions
5. Adverse drug reaction monitoring - Cost and benefit considerations, part II: Cost and preventability of adverse drug reactions leading to hospital admission
6. Use of trade names of drugs in abstracts from pain congresses